[증시키워드] ‘Apple Car’ Kia Motors cooperation theory-E Today

On the 20th, the increase-keywords are #Samsung Electronics #Kia Motors #Hyundai Motors #Fillux #Celltrion.

With Samsung Electronics’ stock price rebounding after six trading days, Kia Motors, Hyundai Motors, and Phillux’s surge in the previous day caught the attention of investors.

In particular, Kia Motors surged 16.64% on the previous day due to the production of Apple and Apple cars, and the stock price exceeded the 80,000 won mark in nine years. According to a domestic economic media, it is known that the Hyundai Motor Group has introduced Kia (Kia Motors) as a partner for joint development of Apple cars.

If Kia and Apple cooperate, Kia Motors’ future business plans are expected to expand to mobility platform companies. Kia recently announced that it will move away from its manufacturing-oriented business model by removing’automotive’ from its mission and changing its logo, and expanding its business area through innovative mobility products and services.

Its core is Plan S, a mid- to long-term strategy. Plan S includes the content that it will take a leading position in the future mobility industry through businesses such as △electric vehicles, △mobility solutions, △mobility services, and △purpose-based vehicles (PBVs).

When Kia Motors was listed in the top search category, Hyundai Motor Company also stood out.

Phillux is reflecting the effect of treatment for the novel coronavirus infection (Corona 19) day after day. On the 12th, it was reported that Genencel, a venture pharmaceutical company that has a strategic alliance with Phillux, has delivered a phase 2 clinical trial for the development of a new drug treatment for Corona 19 in India.

It is analyzed that the share price is also showing an uptrend as it is expected to benefit from Phillux’s future development of COVID-19 treatment.

Samsung Electronics, a regular in the stock market’s top search stocks, is drawing attention from investors. Samsung Electronics Vice Chairman Lee Jae-yong was sentenced to two years and six months in prison at a repatriation trial for the destruction of Gukjeong Nongdan on the 18th, and an investment gap due to the absence of the total number is inevitable.

As the out-of-pocket management has its limitations, attention is paid to whether it will adversely affect the entire Samsung Group.

Celltrion stands out day after day amid controversy over preferential treatment for COVID-19 antibody treatment. Some of the health care industry is encouraging controversy about boosting certain companies, and the visible side believes that it is appropriate support for companies that can speed up the development, taking the case of rapid vaccine development in the US.